---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-026351"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-08-06T21:04:48+00:00"
generated_at: "2026-08-06T21:06:09.189432+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences enters $75M at-the-market equity distribution agreement with Mizuho

## Summary
- Aggregate offering price of up to $75M of common stock via ATM facility.
- Mizuho Securities USA LLC acts as sales agent; commission up to 3.0% of gross proceeds.
- Sales may be made on Nasdaq or in negotiated transactions at prevailing market prices.
- Company is not obligated to sell any shares and may suspend offerings at any time.
- Prospectus supplement filed August 6, 2026 under existing S-3 registration statement.

## SEC filing metadata
- accession: 0001437749-26-026351
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-08-06T21:04:48+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926026351/0001437749-26-026351-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926026351/plse20260806_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-026351
- JSON: https://secwatch.observer/filing/0001437749-26-026351.json
- Plain text: https://secwatch.observer/filing/0001437749-26-026351.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.